TrialPanorama/TrialPanorama-database huggingface dataset:
Study NCT02513667 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study NCT00352599 — Predictive Biomarker (PRD): NF1 mRNA
Genes: NF1
Study NCT01553487 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT02388464 — Predictive Biomarker (PRD): MTTP mRNA
Genes: MTTP; MTP
Study NCT04611334 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT04611334 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT04611334 — Predictive Biomarker (PRD): IL6
Genes: IL-6; BSF2; HGF; HSF
Study NCT00023920 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT00044603 — Predictive Biomarker (PRD): PAH mRNA
Genes: PAH
Study NCT00404976 — Predictive Biomarker (PRD): Exhaled nitric oxide
Study NCT00404976 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT00404976 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT03486509 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT01530854 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Free fatty acids
Study NCT00002866 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT02854033 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Microtubule-associated protein tau
Genes: MAPT; MAPTL; MTBT1; TAU
Study NCT02972346 — Predictive Biomarker (PRD): POMC
Genes: MSH; POC; CLIP; ACTH; NPP; LPH
Study NCT00146172 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT00146172 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT02942784 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Serum albumin
Genes: ALB; GIG20; GIG42; PRO0903; PRO1708; PRO2044; PRO2619; PRO2675; UNQ696/PRO1341
Study NCT02663219 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT03166085 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT01943305 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT02620449 — Pharmacodynamic Biomarker (PDY): Fibroblast growth factor 23
Genes: FGF23; HYPF; UNQ3027/PRO9828
Study NCT00609869 — Predictive Biomarker (PRD): CD5 mRNA
Genes: CD5; LEU1
Study NCT04159402 — Predictive Biomarker (PRD): SEPTIN2 mRNA
Genes: SEPTIN2; DIFF6; KIAA0158; NEDD5; SEPT2
Study NCT03107858 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01458600 — Predictive Biomarker (PRD): PPARA mRNA
Genes: PPARA; NR1C1; PPAR
Study NCT03908606 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT02940145 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT02940145 — Pharmacodynamic Biomarker (PDY): Superoxide dismutase Cu-Zn
Genes: SOD1
Study NCT03998098 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03162796 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT00931762 — Predictive Biomarker (PRD): JAK2 mRNA
Genes: JAK2
Study NCT03931291 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Cellular tumor antigen p53
Genes: TP53; P53
Study NCT01276743 — Predictive Biomarker (PRD): PTPN22 mRNA
Genes: PTPN22; PTPN8
Study NCT02967861 — Predictive Biomarker (PRD): PPARA mRNA
Genes: PPARA; NR1C1; PPAR
Study NCT00817453 — Pharmacodynamic Biomarker (PDY): Synuclein alpha
Genes: SNCA; NACP; PARK1
Study NCT04587219 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT01028287 — Predictive Biomarker (PRD): POMC
Genes: MSH; POC; CLIP; ACTH; NPP; LPH
Study NCT01928459 — Predictive Biomarker (PRD): PIK3CA mRNA
Genes: PIK3CA
Study NCT01332175 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00177619 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT04061824 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04061824 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT03074032 — Predictive Biomarker (PRD): NPEPPS mRNA
Genes: NPEPPS; PSA
Study NCT01488656 — Predictive Biomarker (PRD): Exhaled nitric oxide
Study NCT01488656 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT01354574 — Predictive Biomarker (PRD): CCK mRNA
Genes: CCK
Study NCT01162772 — Pharmacodynamic Biomarker (PDY): Gastric inhibitory polypeptide
Genes: GIP
Study NCT01162772 — Pharmacodynamic Biomarker (PDY): Dipeptidyl peptidase 4
Genes: DPP4; ADCP2; CD26
Study NCT03284970 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT05657210 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT04416334 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT00562614 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02175589 — Predictive Biomarker (PRD): MEFV mRNA
Genes: MEFV; MEF; TRIM20
Study NCT03927196 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02093169 — Safety Biomarker (SAF): DRD2
Study NCT00778076 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT02133547 — Predictive Biomarker (PRD): Exhaled nitric oxide
Study NCT04633148 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT03803475 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT00527267 — Predictive Biomarker (PRD): Intact parathyroid hormone
Study NCT01157299 — Predictive Biomarker (PRD): CFI mRNA
Genes: CFI; IF
Study NCT04198467 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT04275167 — Predictive Biomarker (PRD): EED mRNA
Genes: EED
Study NCT04629313 — Predictive Biomarker (PRD): MIP mRNA
Genes: MIP; AQP0
Study NCT01971112 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT02300467 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT01014936 — Predictive Biomarker (PRD): Proto-oncogene c-Met
Genes: MET
Study NCT01918891 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05554549 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT02009020 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00005943 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT01320085 — Predictive Biomarker (PRD): NRAS mRNA
Genes: NRAS; HRAS1
Study NCT01320085 — Pharmacodynamic Biomarker (PDY): Extracellular signal-regulated kinase
Study NCT01479010 — Safety Biomarker (SAF): Interleukin 1
Study NCT03234478 — Pharmacodynamic Biomarker (PDY): Lysosomal acid glucosylceramidase
Genes: GBA1; GBA; GC; GLUC
Study NCT01015872 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02029443 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase BTK
Genes: BTK; AGMX1; ATK; BPK
Study NCT00325767 — Predictive Biomarker (PRD): MCC mRNA
Genes: MCC
Study NCT03130894 — Predictive Biomarker (PRD): FMO3 mRNA
Genes: FMO3
Study NCT01185041 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04163237 — Predictive Biomarker (PRD): AFP mRNA
Genes: AFP; HPAFP
Study NCT01310166 — Predictive Biomarker (PRD): CCR7 mRNA
Genes: CCR7; CMKBR7; EBI1; EVI1
Study NCT01310166 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT01994057 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT01994057 — Predictive Biomarker (PRD): EML4 mRNA
Genes: EML4; C2orf2; EMAPL4
Study NCT01994057 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study NCT01441947 — Predictive Biomarker (PRD): Hormone receptor
Study NCT03022968 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Microtubule-associated protein tau
Genes: MAPT; MAPTL; MTBT1; TAU
Study NCT02927249 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT02927249 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT01747304 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT02665663 — Predictive Biomarker (PRD): IGFALS mRNA
Genes: IGFALS; ALS
Study NCT03580551 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04121715 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT04121715 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT04121715 — Pharmacodynamic Biomarker (PDY): Superoxide dismutase Cu-Zn
Genes: SOD1
Study NCT03087318 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02966652 — Surrogate Endpoint (SUR): Serum testosterone
Study NCT03844685 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT04239768 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT04031898 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT05329519 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05329519 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT00273052 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study NCT01267643 — Predictive Biomarker (PRD): CD2 mRNA
Genes: CD2; SRBC
Study NCT01267643 — Predictive Biomarker (PRD): CD58 mRNA
Genes: CD58; LFA3
Study NCT01267643 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT03578978 — Predictive Biomarker (PRD): C2 mRNA
Genes: C2
Study NCT03578978 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT00362960 — Safety Biomarker (SAF): Urinary total protein
Study NCT01630226 — Predictive Biomarker (PRD): BRCA1 mRNA
Genes: BRCA1; RNF53
Study NCT03340909 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT02616276 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03764020 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT03764020 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT03627637 — Predictive Biomarker (PRD): ASL mRNA
Genes: ASL
Study NCT02555306 — Predictive Biomarker (PRD): AMD1 mRNA
Genes: AMD1; AMD
Study NCT02298166 — Predictive Biomarker (PRD): FLT3 mRNA
Genes: FLT3; CD135; FLK2; STK1
Study NCT02406092 — Predictive Biomarker (PRD): Leukocyte surface antigen Leu-16
Genes: MS4A1; CD20
Study NCT03214172 — Predictive Biomarker (PRD); Safety Biomarker (SAF): CAT mRNA
Genes: CAT
Study NCT00001719 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02131922 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02157948 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT03971318 — Predictive Biomarker (PRD): Phosphatase and tensin homolog
Genes: PTEN; MMAC1; TEP1
Study NCT01278914 — Predictive Biomarker (PRD): TBXT mRNA
Genes: TBXT; T
Study NCT03041155 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT04477707 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02303067 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00037310 — Predictive Biomarker (PRD): Apolipoprotein E
Genes: APOE
Study NCT00037310 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03510052 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase ABL1
Genes: ABL1; ABL; JTK7
Study NCT01180231 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02509858 — Predictive Biomarker (PRD); Safety Biomarker (SAF): SLC2A4 mRNA
Genes: SLC2A4; GLUT4
Study NCT04486820 — Predictive Biomarker (PRD): CDX2 mRNA
Genes: CDX2; CDX3
Study NCT04486820 — Predictive Biomarker (PRD): INSM1 mRNA
Genes: INSM1; IA1
Study NCT04486820 — Predictive Biomarker (PRD): FOXA1 mRNA
Genes: FOXA1; HNF3A; TCF3A
Study NCT02610322 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02054351 — Predictive Biomarker (PRD): CLDN6 mRNA
Genes: CLDN6; UNQ757/PRO1488
Study NCT04318834 — Predictive Biomarker (PRD): BTC mRNA
Genes: BTC
Study NCT00128973 — Predictive Biomarker (PRD): LAD1 mRNA
Genes: LAD1; LAD
Study NCT00061906 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT00061906 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT02113826 — Predictive Biomarker (PRD): TFE3 mRNA
Genes: TFE3; BHLHE33
Study NCT00964483 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04126577 — Predictive Biomarker (PRD): PLTP mRNA
Genes: PLTP
Study NCT01534546 — Predictive Biomarker (PRD): Thymidylate synthase 
Genes: TYMS; TS; OK/SW-cl.29
Study NCT03926702 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Microtubule-associated protein tau
Genes: MAPT; MAPTL; MTBT1; TAU
Study NCT01833455 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04598594 — Predictive Biomarker (PRD): ACE2 mRNA
Genes: ACE2; UNQ868/PRO1885
Study NCT02765594 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT02765594 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT03709771 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT03709771 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT03709771 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01846299 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT01846299 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT03387540 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT03387540 — Safety Biomarker (SAF): Cytotoxic T-lymphocyte protein 4
Genes: CTLA4; CD152
Study NCT02797132 — Predictive Biomarker (PRD): CFTR mRNA
Genes: CFTR; ABCC7
Study NCT03087890 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT01321255 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01674998 — Predictive Biomarker (PRD): REM1 mRNA
Genes: REM1; GES; REM
Study NCT04559074 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00836498 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT03902197 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT00003204 — Predictive Biomarker (PRD): Leukocyte surface antigen Leu-16
Genes: MS4A1; CD20
Study NCT05558072 — Predictive Biomarker (PRD): TLR4 mRNA
Genes: TLR4
Study NCT01218659 — Predictive Biomarker (PRD): GLA
Genes: GALA
Study NCT01414517 — Predictive Biomarker (PRD): FOS mRNA
Genes: FOS; G0S7
Study NCT03510884 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT04189822 — Predictive Biomarker (PRD): SCD mRNA
Genes: SCD; FADS5; SCD1; SCDOS
Study NCT02851134 — Predictive Biomarker (PRD): NOD2 mRNA
Genes: NOD2; CARD15; IBD1
Study NCT00087022 — Predictive Biomarker (PRD): Carbonic anhydrase IX
Genes: CA9; G250; MN
Study NCT02814851 — Safety Biomarker (SAF): Natriuretic peptides A
Genes: NPPA; ANP; PND
Study NCT01025323 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04690075 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT01006538 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT02564536 — Predictive Biomarker (PRD): DNMT1 mRNA
Genes: DNMT1; AIM; CXXC9; DNMT
Study NCT02498145 — Surrogate Endpoint (SUR): Exhaled carbon monoxide
Study NCT01939509 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03877783 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02644122 — Predictive Biomarker (PRD): PIK3CA mRNA
Genes: PIK3CA
Study NCT02644122 — Predictive Biomarker (PRD); Safety Biomarker (SAF): PIK3CA
Genes: PI3K
Study NCT02795884 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT03227510 — Predictive Biomarker (PRD): AFP mRNA
Genes: AFP; HPAFP
Study NCT02461979 — Predictive Biomarker (PRD): VDR mRNA
Genes: VDR; NR1I1
Study NCT04546776 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT01856569 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT02727634 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02999945 — Predictive Biomarker (PRD): IGF1 mRNA
Genes: IGF1; IBP1
Study NCT03428633 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Neutrophil gelatinase-associated lipocalin
Genes: LCN2; HNL; NGAL
Study NCT03428633 — Pharmacodynamic Biomarker (PDY): Superoxide dismutase Cu-Zn
Genes: SOD1
Study NCT03905512 — Surrogate Endpoint (SUR): Serum uric acid
Study NCT00309751 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT00005760 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02115659 — Surrogate Endpoint (SUR): Total kidney volume
Study NCT00056654 — Surrogate Endpoint (SUR): Serum testosterone
Study NCT01463475 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study NCT03611088 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04561089 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT01824901 — Predictive Biomarker (PRD): FGFR1 mRNA
Genes: FGFR1; BFGFR; CEK; FGFBR; FLG; FLT2; HBGFR
Study NCT01824901 — Pharmacodynamic Biomarker (PDY): Fibroblast growth factor receptor
Study NCT00003984 — Predictive Biomarker (PRD): Myeloid cell surface antigen CD33
Genes: CD33; SIGLEC3
Study NCT03773679 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT06699667 — Predictive Biomarker (PRD): AIP mRNA
Genes: AIP; XAP2
Study NCT06699667 — Predictive Biomarker (PRD): CP mRNA
Genes: CP
Study NCT00716170 — Pharmacodynamic Biomarker (PDY): Gastric inhibitory polypeptide
Genes: GIP
Study NCT00536120 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT00536120 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT06445465 — Pharmacodynamic Biomarker (PDY): Synuclein alpha
Genes: SNCA; NACP; PARK1
Study NCT03986242 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT02634684 — Predictive Biomarker (PRD): AMPH mRNA
Genes: AMPH; AMPH1
Study NCT01911156 — Monitoring Biomarker (MOI): HBV DNA
Study NCT00692913 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT03627429 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT00479375 — Surrogate Endpoint (SUR): Cervical intraepithelial neoplasia
Study NCT01462175 — Predictive Biomarker (PRD): MDM2 mRNA
Genes: MDM2
Study NCT01462175 — Predictive Biomarker (PRD); Safety Biomarker (SAF): TP53
Genes: p53; LFS1
Study NCT04316754 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01550380 — Predictive Biomarker (PRD): PIK3CA mRNA
Genes: PIK3CA
Study NCT01550380 — Predictive Biomarker (PRD): Phosphatase and tensin homolog
Genes: PTEN; MMAC1; TEP1
Study NCT03754660 — Predictive Biomarker (PRD): PVR mRNA
Genes: PVR; PVS
Study NCT03754660 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03754660 — Surrogate Endpoint (SUR): Pulmonary vascular resistance
Study NCT00387075 — Predictive Biomarker (PRD): CIT mRNA
Genes: CIT; CRIK; KIAA0949; STK21
Study NCT00387075 — Safety Biomarker (SAF): SLC6A3
Genes: DAT
Study NCT01779050 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT02666404 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00815100 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT00764166 — Predictive Biomarker (PRD): PC mRNA
Genes: PC
Study NCT01692769 — Surrogate Endpoint (SUR): Serum sodium
Study NCT01692769 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT01692769 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Interleukin 8
Genes: CXCL8; IL8
Study NCT04535856 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study NCT01079806 — Monitoring Biomarker (MOI): HBV DNA
Study NCT02343666 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study NCT02343666 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT01478594 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT01478594 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT04678037 — Predictive Biomarker (PRD): SCD mRNA
Genes: SCD; FADS5; SCD1; SCDOS
Study NCT01928875 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01386372 — Surrogate Endpoint (SUR): Serum sodium
Study NCT01386372 — Predictive Biomarker (PRD): Arginine vasopressin
Genes: AVP; ARVP; VP
Study NCT01154504 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Adrenomedullin
Genes: ADM; AM
Study NCT04056754 — Predictive Biomarker (PRD); Safety Biomarker (SAF): CYP17A1 mRNA
Genes: CYP17A1; CYP17; S17AH
Study NCT02920034 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03879538 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01530334 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT01530334 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT01267617 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02377193 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Interleukin 2 receptor alpha
Genes: IL2RA
Study NCT02912247 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT00426205 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT03089359 — Monitoring Biomarker (MOI): Urokinase plasminogen activator surface receptor
Genes: PLAUR; MO3; UPAR
Study NCT00856362 — Predictive Biomarker (PRD): CYP3A4 mRNA
Genes: CYP3A4; CYP3A3
Study NCT00509756 — Predictive Biomarker (PRD): NR1H4 mRNA
Genes: NR1H4; BAR; FXR; HRR1; RIP14
Study NCT01122914 — Safety Biomarker (SAF): Interleukin 1
Study NCT00827385 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03470805 — Predictive Biomarker (PRD): BRCA1 mRNA
Genes: BRCA1; RNF53
Study NCT03470805 — Predictive Biomarker (PRD): Homologous recombination deficiency
Study NCT04197791 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT00884026 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01608685 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Interferon gamma
Genes: IFNG
Study NCT00291694 — Predictive Biomarker (PRD): Ki-67
Genes: MKI67; MIB-1; PPP1R105